Login Register Cart 0
Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

COVID-19: An Update on Clinical Trials

Author(s): Yogesh Kumar, Anil Kumar Singh and Shiv Kumar

Volume 20, Issue 17, 2020

Page: [1516 - 1517] Pages: 2

DOI: 10.2174/1568026620999200511092332

« Previous Next »
[1]
Li, W.; Shi, Z.; Yu, M.; Ren, W.; Smith, C; Epstein, J. H.; Wang, H.; Crameri, G.; Hu, Z.; Zhang, H.; Zhang, J.; McEachern, J.; Field, H.; Daszak, P.; Eaton, B. T.; Zhang, S.; Wang, L.F. Bats are natural reservoirs of SARS-like coronaviruses. Science, 2005, 310, 676-679.
[2]
Revised US. surveillance case definition for severe acute respiratory syndrome (SARS) and update on SARS cases—United States and worldwide, December 2003. Morb. Mortal Wkly Rep., 2003, 52, 1202-1206.
[3]
World Health Organization.; Middle East respiratory syndrome coronavirus (MERS-CoV). Fact sheet. , 2017. Available from:. [https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov).]
[4]
WHO.; Director-General’s opening remarks at the media briefing on COVID-19- 11 March. 2020.Available from:. https://www.who.int/dg/speeches/detail/whodirectorgenerals-opening-remarks-atthe-media-briefing-on-covid-19-11-march-2020.
[5]
An update on coronavirus infected person- (Accessed on May 02, 2020).Available from:. https://www.worldometers.info/coronavirus/
[6]
Dyall, J.; Gross, R.; Kindrachuk, J.; Johnson, R. F.; Olinger Jr., G. G.; Hensley, L. E.; Frieman, M. B.; Jahrling, P. B. Middle east respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies. Drugs, 2017, 77, 1935-1966.
[7]
Browning, D. J. Toxicology of hydroxychloroquine and chloroquine and the pathology of the retinopathy they cause. In: Hydroxychloroquine and chloroquine retinopathy. Springer: New York, 2014, pp. 65-83.
[8]
Savarino, A.; Lucia, M.B.; Rastrelli, E.; Rutella, S.; Golotta, C.; Morra, E.; Tamburrini, E.; Perno, C.F.; Boelaert, J.R.; Sperber, K.; Cauda, R. Anti- HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors. J. Acquir. Immune. Defic. Syndr., 2004, 35, 223-232.
[9]
Dong, L.; Hu, S.; Gao, J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov. Ther., 2020, 14, 58-60.
[10]
Wang, M.; Cao, R.; Zhang, L.; Yang, X.; Liu, J.; Xu, M.; Shi, Z.; Hu, Z.; Zhong, W.; Xiao, G. Remdesivir and chloroquine effectively inhibit the recently emerged novel corona virus (2019-nCoV) in vitro. Cell Res., 2020, 30, 269-271.
[11]
Li, G.; Clercq, E.D. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat. Rev. Drug Discov., 2020, 19, 149-150.
[12]
Callaway, E.; Spence, N. The race for coronavirus. Nature, 2020, 580, 576-577.
[13]
Ren, J.L.; Zhang, A.H.; Wang, X.J. Traditional chinese medicine for COVID-19 treatment. Pharmacol. Res., 2020, 155104743
[14]
Chen, L.; Xiong, J.; Bao, L.; Shi, Y. Convalescent plasma as a potential therapy for COVID-19. Lancet Infect. Dis., 2020, 20, 398-400.

Rights & Permissions Print Cite
Article Metrics
41
3
1
1
© 2025 Bentham Science Publishers | Privacy Policy